1 00:00:01,080 --> 00:00:03,400 Speaker 1: My name is Lily Maddon and I'm a proud Arunda 2 00:00:03,640 --> 00:00:08,400 Speaker 1: Bungelung Cargoton woman from Gadighl country. The Daily oz acknowledges 3 00:00:08,480 --> 00:00:10,680 Speaker 1: that this podcast is recorded on the lands of the 4 00:00:10,680 --> 00:00:14,240 Speaker 1: Gadighl people and pays respect to all Aboriginal and Torres 5 00:00:14,240 --> 00:00:17,200 Speaker 1: Strait Island and nations. We pay our respects to the 6 00:00:17,200 --> 00:00:19,960 Speaker 1: first peoples of these countries, both past and present. 7 00:00:25,640 --> 00:00:28,480 Speaker 2: Good morning and welcome to the Daily OS. It's Thursday, 8 00:00:28,520 --> 00:00:31,640 Speaker 2: the nineteenth of October. I'm Zara, I'm Emma Gillespie. 9 00:00:31,680 --> 00:00:33,640 Speaker 3: I'm the deputy editor here at the Daily OS. 10 00:00:33,680 --> 00:00:36,159 Speaker 2: You might have noticed that we are changing up the 11 00:00:36,200 --> 00:00:38,720 Speaker 2: regular lineup a bit. There has been a bit of 12 00:00:38,720 --> 00:00:41,280 Speaker 2: flux in the TDA office with a few people taking 13 00:00:41,360 --> 00:00:43,720 Speaker 2: leave at the same time. But I'm so glad to 14 00:00:43,760 --> 00:00:46,680 Speaker 2: be joined by m today again. What are we talking 15 00:00:46,680 --> 00:00:47,280 Speaker 2: about today? 16 00:00:47,560 --> 00:00:50,000 Speaker 3: Very happy to be here today because we've got a 17 00:00:50,080 --> 00:00:53,519 Speaker 3: really interesting one to discuss. We're talking about a new 18 00:00:53,560 --> 00:00:56,760 Speaker 3: treatment option for depression that's been popping up around the 19 00:00:56,760 --> 00:00:57,800 Speaker 3: country in clinics. 20 00:00:58,040 --> 00:01:01,560 Speaker 2: The Royal Melbourne Hospital recently own opened the third public 21 00:01:01,600 --> 00:01:05,119 Speaker 2: clinic in the country to offer kenemine treatment for patients 22 00:01:05,280 --> 00:01:09,000 Speaker 2: with what's called treatment resistant depression. Now that's a type 23 00:01:09,040 --> 00:01:13,400 Speaker 2: of depression that doesn't respond to antidepressant medication or other treatments. 24 00:01:13,640 --> 00:01:16,800 Speaker 3: Yep. So I'm chatting with Black Dog Institute researcher doctor 25 00:01:16,800 --> 00:01:20,120 Speaker 3: Adam Bayes to understand what that means and how it 26 00:01:20,200 --> 00:01:21,160 Speaker 3: all works next. 27 00:01:21,360 --> 00:01:27,679 Speaker 2: But first, m here's what's making headlines. US President Joe 28 00:01:27,680 --> 00:01:31,240 Speaker 2: Biden has met with Israeli PM Benjamin Manetta Yahu in 29 00:01:31,319 --> 00:01:35,080 Speaker 2: Tel Aviv after arriving in the country last night. A 30 00:01:35,080 --> 00:01:39,400 Speaker 2: meeting with Palestinian Authority President Mahmurabas set to take place today, 31 00:01:40,040 --> 00:01:43,040 Speaker 2: was canceled after hundreds of Palestinians were killed when a 32 00:01:43,120 --> 00:01:46,679 Speaker 2: rocket hit a hospital in Gaza. Garz In Health Authority 33 00:01:46,720 --> 00:01:49,240 Speaker 2: said the blast was caused by an Israeli air strike, 34 00:01:49,360 --> 00:01:52,360 Speaker 2: while the Israeli Defense Forces blamed it on a misfire 35 00:01:52,720 --> 00:01:56,760 Speaker 2: by a group called Palestinian Islamic Jihad. On this and 36 00:01:56,840 --> 00:01:59,960 Speaker 2: I quote, Biden said, based on the information we've seen 37 00:02:00,200 --> 00:02:02,960 Speaker 2: to date, it appears the result of an errant rocket 38 00:02:03,000 --> 00:02:07,200 Speaker 2: fired by a terrorist group from Gaza. Biden also announced 39 00:02:07,240 --> 00:02:10,440 Speaker 2: one hundred million US dollars for humanitarian aid in Gaza 40 00:02:10,520 --> 00:02:11,600 Speaker 2: and the West Bank. 41 00:02:14,280 --> 00:02:18,280 Speaker 3: Non fatal strangulation would become a standalone offense under new 42 00:02:18,360 --> 00:02:23,359 Speaker 3: legislation tabled in Victoria on Wednesday. Intentional non fatal strangulation 43 00:02:23,520 --> 00:02:26,480 Speaker 3: without proof of injury could result in up to five 44 00:02:26,600 --> 00:02:30,079 Speaker 3: years imprisonment, which would rise to ten years for more 45 00:02:30,120 --> 00:02:33,919 Speaker 3: serious offenses. The reforms have been tabled to protect victim 46 00:02:34,040 --> 00:02:39,040 Speaker 3: survivors and hold perpetrators to account. 47 00:02:39,480 --> 00:02:42,360 Speaker 2: New laws to increase paid parental leave will be tabled 48 00:02:42,400 --> 00:02:46,119 Speaker 2: in federal Parliament today. Under the proposal, paid parental leave 49 00:02:46,160 --> 00:02:49,520 Speaker 2: would increase to twenty six weeks in July twenty twenty six, 50 00:02:49,720 --> 00:02:52,960 Speaker 2: with incremental increases to parental leave in the years leading 51 00:02:53,040 --> 00:02:56,160 Speaker 2: up to that point. The reforms were first announced by 52 00:02:56,160 --> 00:02:58,800 Speaker 2: the government last year to raise paid parental leave from 53 00:02:58,880 --> 00:03:02,040 Speaker 2: eighteen weeks. New parents will also be allowed to take 54 00:03:02,120 --> 00:03:05,160 Speaker 2: four weeks of concurrent leave, meaning both parents can go 55 00:03:05,200 --> 00:03:08,000 Speaker 2: on paid leave at the same time from twenty twenty six. 56 00:03:08,600 --> 00:03:11,000 Speaker 2: The government says it will send a strong signal that 57 00:03:11,080 --> 00:03:13,800 Speaker 2: both parents play a role in caring for their children. 58 00:03:15,280 --> 00:03:17,720 Speaker 2: And the good news the soccer rows have won something 59 00:03:17,800 --> 00:03:20,800 Speaker 2: I had never yet heard before, the soccer ashes. It 60 00:03:20,880 --> 00:03:24,080 Speaker 2: follows a two nil victory against New Zealand in London. 61 00:03:24,440 --> 00:03:27,400 Speaker 2: The Soccer Ashes is a trophy containing the ashes of 62 00:03:27,480 --> 00:03:31,000 Speaker 2: cigars smoked by the captains of Australia and New Zealand 63 00:03:31,080 --> 00:03:34,840 Speaker 2: after a match in nineteen twenty three. The trophy disappeared 64 00:03:34,840 --> 00:03:37,560 Speaker 2: in nineteen fifty four and was rediscovered in a suburban 65 00:03:37,600 --> 00:03:40,840 Speaker 2: garage earlier this year. While this story took quite the turn, 66 00:03:41,240 --> 00:03:43,360 Speaker 2: the soccer Us will play their next match in Melbourne 67 00:03:43,400 --> 00:03:50,320 Speaker 2: in one month. Ketamine is commonly used in medicine and 68 00:03:50,520 --> 00:03:55,080 Speaker 2: by vets as an anesthetic. It's a disassociative drug, meaning 69 00:03:55,200 --> 00:03:57,960 Speaker 2: it acts on brain chemicals and it can stop the 70 00:03:57,960 --> 00:04:02,360 Speaker 2: brain from interpreting pain messages. Now it's also being used 71 00:04:02,360 --> 00:04:05,440 Speaker 2: to treat depression, after low doses of the drug were 72 00:04:05,440 --> 00:04:09,360 Speaker 2: found to quickly and significantly improve depressive symptoms. 73 00:04:09,600 --> 00:04:11,520 Speaker 3: We know a lot of young people, a lot of 74 00:04:11,600 --> 00:04:15,360 Speaker 3: TDA listeners live with depression, but for some people traditional 75 00:04:15,400 --> 00:04:20,719 Speaker 3: treatment options like antidepressants therapy that doesn't always actually work. 76 00:04:21,040 --> 00:04:23,560 Speaker 3: So for those people and others who might not be 77 00:04:23,600 --> 00:04:27,719 Speaker 3: able to take antidepressant medication for other reasons, ketymine treatment 78 00:04:27,800 --> 00:04:31,120 Speaker 3: could actually change the way mental ill health is treated 79 00:04:31,200 --> 00:04:34,560 Speaker 3: in Australia. But honestly, I had never actually heard of 80 00:04:34,640 --> 00:04:37,040 Speaker 3: ketamine being used in this way before this point Zza, 81 00:04:37,240 --> 00:04:39,880 Speaker 3: so you can imagine I had a lot of questions 82 00:04:40,360 --> 00:04:43,320 Speaker 3: and I put those to an expert in this field. 83 00:04:43,680 --> 00:04:46,280 Speaker 3: Dr Adam Bays is a Senior Research Fellow at the 84 00:04:46,279 --> 00:04:50,440 Speaker 3: Black Talk Institute. He is a clinical academic psychiatrist with 85 00:04:50,520 --> 00:04:54,040 Speaker 3: a special interest in mood disorders. Dr Adam Bays, Welcome 86 00:04:54,160 --> 00:04:55,040 Speaker 3: to the podcast. 87 00:04:55,160 --> 00:04:55,880 Speaker 4: Thanks for having me. 88 00:04:56,120 --> 00:04:59,320 Speaker 3: First of all, what is ketamine and why is it 89 00:04:59,520 --> 00:05:02,440 Speaker 3: useful in clinical settings to treat depression. 90 00:05:02,839 --> 00:05:06,479 Speaker 4: Petamine is a anesthetic drug that's been around for a 91 00:05:06,480 --> 00:05:09,560 Speaker 4: long time. About twenty years ago, there was some pivotal 92 00:05:09,880 --> 00:05:14,000 Speaker 4: studies where there was sub aesthetic doses ketamine, so smaller 93 00:05:14,000 --> 00:05:18,200 Speaker 4: doses administered to patients with treatment resistant depression. So this 94 00:05:18,240 --> 00:05:21,640 Speaker 4: is where patients have failed multiple trials or standard treatments 95 00:05:21,800 --> 00:05:25,120 Speaker 4: oral antidepressant psychological therapies, and it was found to have 96 00:05:25,360 --> 00:05:29,520 Speaker 4: both a rapid antidepressant effect and also the effect was 97 00:05:29,640 --> 00:05:33,200 Speaker 4: quite pronounced, so quite a large impact on depression. And 98 00:05:33,279 --> 00:05:36,359 Speaker 4: since that time, there's been more and more research into 99 00:05:36,400 --> 00:05:40,000 Speaker 4: the area of ketamine for treatment resistant depression, and it's 100 00:05:40,000 --> 00:05:42,000 Speaker 4: been found to be very effective in that patient group. 101 00:05:42,240 --> 00:05:46,160 Speaker 3: What do we know about the scale of treatment resistant depression? 102 00:05:46,240 --> 00:05:48,320 Speaker 3: You know, what is it that we understand about it? 103 00:05:48,480 --> 00:05:51,680 Speaker 4: Obviously, you know depression, it's a complex diagnosis and there's 104 00:05:51,680 --> 00:05:54,840 Speaker 4: different sort of manifestations of depression. So there's more mild 105 00:05:55,080 --> 00:05:58,920 Speaker 4: forms of depression that might be the result of life circumstances, 106 00:05:59,160 --> 00:06:01,159 Speaker 4: and then all the way through to the more severe 107 00:06:01,440 --> 00:06:03,840 Speaker 4: biological forms of depression where there might be a strong 108 00:06:03,880 --> 00:06:08,239 Speaker 4: family history of depression. It starts need to use medications 109 00:06:08,279 --> 00:06:12,240 Speaker 4: like antidepressants or other drugs, and in the severe cases, 110 00:06:12,480 --> 00:06:15,800 Speaker 4: things like electroc convulsive therapy or ECT is still a 111 00:06:16,040 --> 00:06:19,719 Speaker 4: highly effective treatment. And it's probably around about a third 112 00:06:19,720 --> 00:06:22,600 Speaker 4: of patients specified as having treatment resistant depression, so it's 113 00:06:22,680 --> 00:06:23,479 Speaker 4: quite a high number. 114 00:06:23,640 --> 00:06:25,880 Speaker 3: Yeah, that's a really significant number. I think that will 115 00:06:25,880 --> 00:06:28,640 Speaker 3: come as a surprise to a fair few of our listeners. 116 00:06:29,120 --> 00:06:33,720 Speaker 3: In terms of treatment options for this difficult to treat depression, 117 00:06:34,560 --> 00:06:38,359 Speaker 3: are there many options? And you've mentioned DCT, but considering 118 00:06:38,360 --> 00:06:42,039 Speaker 3: that ketamine treatment is a relatively new kind of phenomenon. 119 00:06:41,880 --> 00:06:45,920 Speaker 4: There have been exciting advancements also in neurosimulations, so things 120 00:06:45,960 --> 00:06:50,800 Speaker 4: like transcranial magnetic stimulation or TMS, which is very powerful 121 00:06:50,839 --> 00:06:54,960 Speaker 4: magnets brought close to the skull. But ketamine is exciting 122 00:06:55,000 --> 00:06:57,360 Speaker 4: in the sense that in mental health it's good to 123 00:06:57,360 --> 00:06:59,920 Speaker 4: have an assortment of different options. Yeah, it just gives 124 00:07:00,560 --> 00:07:02,120 Speaker 4: yet another option to get well. 125 00:07:02,200 --> 00:07:02,560 Speaker 2: A lot of. 126 00:07:02,560 --> 00:07:07,480 Speaker 3: People may have only heard of ketamine used illegally or 127 00:07:07,520 --> 00:07:11,440 Speaker 3: as an anesthetic. How does this treatment work, how long 128 00:07:11,480 --> 00:07:13,240 Speaker 3: does it take, and how does it differ in that 129 00:07:13,320 --> 00:07:16,320 Speaker 3: clinical setting from other uses of ketamine. 130 00:07:16,360 --> 00:07:19,360 Speaker 4: We would have heard of people recreationally using ketamine, and 131 00:07:19,360 --> 00:07:23,480 Speaker 4: this is because it can cause that dissociative effects and 132 00:07:23,560 --> 00:07:26,320 Speaker 4: have these sort of psychoactive effects. But I guess I'm 133 00:07:26,360 --> 00:07:29,880 Speaker 4: talking about it very much in a clinical medical setting, 134 00:07:30,240 --> 00:07:34,240 Speaker 4: where the drug is one hundred percent pure pharmaceutical grade 135 00:07:34,280 --> 00:07:37,480 Speaker 4: ketamine and it's diministered in a setting and patients are 136 00:07:37,520 --> 00:07:41,320 Speaker 4: carefully screened. Patients are usually on an antidepressant as well. 137 00:07:41,440 --> 00:07:44,920 Speaker 4: It can be administered in various ways. It's either usually 138 00:07:44,960 --> 00:07:49,200 Speaker 4: injected under medical supervision, or there is a form called 139 00:07:49,320 --> 00:07:54,080 Speaker 4: sketamine which is intranasal spray. So the ketamine tends to 140 00:07:54,400 --> 00:07:57,760 Speaker 4: have its maximal antidepressant effect the next day, and then 141 00:07:57,800 --> 00:08:00,560 Speaker 4: it does tend to wear off, and so patients then 142 00:08:00,640 --> 00:08:03,960 Speaker 4: have usually a second treatment. At least in the acute course, 143 00:08:04,240 --> 00:08:06,600 Speaker 4: you're trying to get the patient from being in a 144 00:08:06,600 --> 00:08:09,560 Speaker 4: major depressive episode. The goal is to get them into 145 00:08:09,640 --> 00:08:12,680 Speaker 4: remission where they're not no longer meeting criteria for depression. 146 00:08:12,960 --> 00:08:17,440 Speaker 4: It works quite differently to standard antidepressant treatments like you know, 147 00:08:17,480 --> 00:08:21,360 Speaker 4: your SSRIs or Prozac as the brand name of a 148 00:08:21,400 --> 00:08:24,880 Speaker 4: famous SSRI, and these act on the serotonin system. This 149 00:08:25,000 --> 00:08:28,960 Speaker 4: is the kind of feel good neurotransmitter. Ketemine actually doesn't 150 00:08:29,000 --> 00:08:33,120 Speaker 4: act at least directly on serotonin, but it actually acts 151 00:08:33,160 --> 00:08:36,160 Speaker 4: on a completely different set of receptors. And I guess 152 00:08:36,200 --> 00:08:38,880 Speaker 4: the other thing is, yes, it works much more rapidly 153 00:08:39,240 --> 00:08:42,720 Speaker 4: than standard oral antidepressants. At least in some cases, you 154 00:08:42,760 --> 00:08:47,559 Speaker 4: can see patients significantly improved the next day. So that's 155 00:08:47,800 --> 00:08:51,520 Speaker 4: pretty incredible. And I think sometimes people think that the 156 00:08:51,600 --> 00:08:54,559 Speaker 4: patient might be sort of getting high, it's not that. 157 00:08:54,960 --> 00:08:58,480 Speaker 4: So while they have the acute effects of ketamine and 158 00:08:58,480 --> 00:09:01,480 Speaker 4: they might feel dissociated and have some kind of an 159 00:09:01,559 --> 00:09:05,320 Speaker 4: unusual experience that wears off within the first hour, and 160 00:09:05,360 --> 00:09:08,040 Speaker 4: they usually discharged the two hour mark and they feel 161 00:09:08,040 --> 00:09:10,760 Speaker 4: completely back to you know, they don't have any kind 162 00:09:10,800 --> 00:09:13,880 Speaker 4: of association, but we're talking about it's actually an antidepressant 163 00:09:13,920 --> 00:09:15,920 Speaker 4: effect that's more enduring. 164 00:09:16,280 --> 00:09:19,959 Speaker 3: How is the long term or longer term success then 165 00:09:20,080 --> 00:09:23,640 Speaker 3: of this treatment measured. If there's that sort of immediate 166 00:09:23,840 --> 00:09:27,760 Speaker 3: relief of maybe depressive symptoms, is this a treatment that 167 00:09:27,920 --> 00:09:31,240 Speaker 3: is life long for people with treatment resistant depression. 168 00:09:31,600 --> 00:09:35,720 Speaker 4: Yeah, it's a great question. I think Initially there was 169 00:09:36,120 --> 00:09:39,840 Speaker 4: certainly hope that patients might, say, receive a course of ketamines, 170 00:09:39,880 --> 00:09:43,600 Speaker 4: to say, a four week course for example, then they'll 171 00:09:43,640 --> 00:09:48,320 Speaker 4: remain well. Certainly you do see that in some patients. Clinically, though, 172 00:09:48,360 --> 00:09:50,960 Speaker 4: what we're seeing is some patients go into what we 173 00:09:51,000 --> 00:09:54,920 Speaker 4: call maintenance treatments, and this might mean that they have 174 00:09:54,960 --> 00:09:57,920 Speaker 4: a treatment, say every week, or maybe stretched out to 175 00:09:57,960 --> 00:10:01,920 Speaker 4: every two or three weeks, which keeps them well. 176 00:10:01,880 --> 00:10:07,839 Speaker 3: As can happen with other medications. Is there a dependency 177 00:10:08,400 --> 00:10:12,280 Speaker 3: over time or a resistance perhaps over time to ketamine treatment. 178 00:10:12,400 --> 00:10:15,480 Speaker 4: You can't become addicted as such to a surprise act, 179 00:10:15,559 --> 00:10:20,360 Speaker 4: right ketamine. That is actually possible. While we don't tend 180 00:10:20,400 --> 00:10:23,080 Speaker 4: to see that in clinical settings, it's something to be 181 00:10:23,120 --> 00:10:26,760 Speaker 4: mindful of, and that's why it's also a restricted substance. 182 00:10:26,840 --> 00:10:29,120 Speaker 4: We're very cautious about that because we're not wanting to 183 00:10:29,240 --> 00:10:32,280 Speaker 4: create a further problem for the patient. We put a 184 00:10:32,280 --> 00:10:36,319 Speaker 4: lot of time into ensuring they're not becoming dependent. It's 185 00:10:36,360 --> 00:10:39,080 Speaker 4: also why ketamine is administered in the clinic. 186 00:10:39,320 --> 00:10:42,360 Speaker 3: Are there any other risks or sort of safety concerns 187 00:10:42,400 --> 00:10:44,840 Speaker 3: associated with receiving the treatment? 188 00:10:45,200 --> 00:10:48,640 Speaker 4: Yeah, look there are, and I think like any medication 189 00:10:49,120 --> 00:10:51,720 Speaker 4: you know, has a side effect profile, and keta means 190 00:10:51,760 --> 00:10:54,719 Speaker 4: no different. So some of the key things that we 191 00:10:54,800 --> 00:10:59,200 Speaker 4: monitor for. There can be blood pressure increases, certainly acutely 192 00:10:59,240 --> 00:11:02,679 Speaker 4: as well. Patients you can become dissociated, unsteady on their fee. 193 00:11:03,000 --> 00:11:06,040 Speaker 4: Then in the long run I mentioned risk of dependence. 194 00:11:06,200 --> 00:11:09,880 Speaker 4: Ketamine can irritate the bladder and sometimes ketamine can affect 195 00:11:09,880 --> 00:11:12,240 Speaker 4: the liver. You know, ketamine services that are out there, 196 00:11:12,360 --> 00:11:15,840 Speaker 4: they should be monitoring for accus and cumulative cyber effects. 197 00:11:15,920 --> 00:11:18,959 Speaker 3: I noted that at least in the clinic that recently 198 00:11:19,040 --> 00:11:23,000 Speaker 3: opened in Melbourne, that young people are excluded under twenty 199 00:11:23,040 --> 00:11:26,480 Speaker 3: fives are excluded from accessing the treatment. I guess this 200 00:11:26,559 --> 00:11:29,959 Speaker 3: ties into kind of broader questions about barriers to access, 201 00:11:30,120 --> 00:11:33,200 Speaker 3: you know, cost, who can access it, so you know 202 00:11:33,240 --> 00:11:34,760 Speaker 3: the kind of demand versus that. 203 00:11:34,840 --> 00:11:37,480 Speaker 4: I mean generally it's eighteen and over purely because there's 204 00:11:37,559 --> 00:11:41,480 Speaker 4: more data on the safety and effectiveness in that age group. 205 00:11:41,760 --> 00:11:44,800 Speaker 4: I know that there has been a big multisensor study 206 00:11:45,000 --> 00:11:48,840 Speaker 4: looking at ketamine and younger people that have depression. You 207 00:11:48,920 --> 00:11:52,240 Speaker 4: mentioned cost. It's a big one because ketamine is it's 208 00:11:52,280 --> 00:11:54,920 Speaker 4: sort of in this interesting zone where it's you've got 209 00:11:54,920 --> 00:11:58,800 Speaker 4: the two formulations. The anesthetic who's been around for fifty 210 00:11:58,880 --> 00:12:01,240 Speaker 4: years or Medica have a kind of license and they 211 00:12:01,240 --> 00:12:05,360 Speaker 4: have indication. It still remains only licensed for anesthesia. If 212 00:12:05,400 --> 00:12:09,240 Speaker 4: it's administered for anything other than anesthesia, it's it's off label. 213 00:12:09,720 --> 00:12:13,960 Speaker 4: Then there's the new formulation, which is intranasal s ketamine, 214 00:12:14,000 --> 00:12:16,280 Speaker 4: so it's a variant of ketamine. But that has been 215 00:12:16,400 --> 00:12:19,959 Speaker 4: TGA approved in Australia. But the issue is it's not 216 00:12:20,080 --> 00:12:22,680 Speaker 4: covered by the PBS yet. There's a period of time 217 00:12:22,720 --> 00:12:25,120 Speaker 4: where the drug companies have to make a case to 218 00:12:25,160 --> 00:12:28,480 Speaker 4: the government, you know, will you subsidize this drug. So 219 00:12:28,600 --> 00:12:31,199 Speaker 4: patients can certainly go out and you know, they see 220 00:12:31,240 --> 00:12:35,920 Speaker 4: their psychiatrist. Their psychiatrists might recommend the internasales ketamine, but 221 00:12:36,160 --> 00:12:39,640 Speaker 4: it's anywhere between six to eight hundred dollars per dose. 222 00:12:40,040 --> 00:12:40,360 Speaker 3: Wow. 223 00:12:40,880 --> 00:12:43,160 Speaker 4: So and the usual dosing, as I said, is twice 224 00:12:43,160 --> 00:12:46,000 Speaker 4: per week initially for the first four weeks. So that's 225 00:12:46,400 --> 00:12:49,800 Speaker 4: that's a big cost, right ENRMS. That's sixteen hundred dollars 226 00:12:50,000 --> 00:12:53,480 Speaker 4: or more per week per week, and that's because it's 227 00:12:53,559 --> 00:12:56,840 Speaker 4: not on the PBS. The other thing is when you 228 00:12:56,880 --> 00:12:59,839 Speaker 4: go and see a doctor, most things have an item 229 00:13:00,440 --> 00:13:03,800 Speaker 4: So for example, if you go and have your appendix removed, 230 00:13:04,080 --> 00:13:07,599 Speaker 4: there'd be a sort of item number. Medicare reimburses you 231 00:13:07,720 --> 00:13:10,400 Speaker 4: or covers that. Right. So for ketamine treatment, which as 232 00:13:10,440 --> 00:13:12,840 Speaker 4: I explained, you know it involves coming in to the 233 00:13:12,880 --> 00:13:16,000 Speaker 4: clinic there, you monitored, you've seen by a psychiatrists. Is 234 00:13:16,040 --> 00:13:19,040 Speaker 4: two hours of monitoring, and you discharge. There's no item 235 00:13:19,120 --> 00:13:21,000 Speaker 4: number for that, not just the drug, but for the 236 00:13:21,040 --> 00:13:24,000 Speaker 4: whole process. There's no item number. So again, all of 237 00:13:24,040 --> 00:13:26,959 Speaker 4: that clinical time is paid for out of pocket by 238 00:13:26,960 --> 00:13:29,960 Speaker 4: the patient. So at the moment we are in a 239 00:13:30,000 --> 00:13:34,120 Speaker 4: situation where, other than there's a few public clinics where 240 00:13:34,120 --> 00:13:37,439 Speaker 4: it's sort of subsidized by whatever funds the hospital might have, 241 00:13:37,760 --> 00:13:39,240 Speaker 4: the patient pays out of. 242 00:13:39,160 --> 00:13:40,800 Speaker 3: Pocket waiting for that magic number. 243 00:13:40,920 --> 00:13:43,080 Speaker 4: Yeah, it's a big issue really because you know, it 244 00:13:43,160 --> 00:13:47,040 Speaker 4: speaks to you know, inequality and equity, and particularly I 245 00:13:47,040 --> 00:13:49,760 Speaker 4: guess younger people are less likely to have the funds. 246 00:13:50,000 --> 00:13:53,560 Speaker 3: Do you think there's any stigma associated with the idea 247 00:13:53,800 --> 00:13:57,960 Speaker 3: or the reputation of ketamine that may have impacted access. 248 00:13:58,600 --> 00:14:02,560 Speaker 4: I think there is some stigma in the sense of certainly, 249 00:14:02,559 --> 00:14:05,240 Speaker 4: whenever I read a newspaper article, or at least up 250 00:14:05,320 --> 00:14:07,920 Speaker 4: until a few years ago, it would always say horse tranquilizer, 251 00:14:08,040 --> 00:14:11,720 Speaker 4: which is I always found a bit sensationalist because ketamine 252 00:14:11,800 --> 00:14:14,280 Speaker 4: is used as a regular anesthetic in human It was. 253 00:14:14,280 --> 00:14:18,000 Speaker 3: Only researching for this podcast that I realized that horse 254 00:14:18,000 --> 00:14:20,480 Speaker 3: tranquilizer wasn't the original purpose. 255 00:14:21,480 --> 00:14:24,800 Speaker 4: It's a bit sensationalist. And whereas ketamine is used day in, 256 00:14:24,880 --> 00:14:28,080 Speaker 4: day out in surgeries, it's used in children for the 257 00:14:28,120 --> 00:14:31,440 Speaker 4: purposes of anesthesia, I guess the recreational use, et cetera. 258 00:14:31,600 --> 00:14:34,440 Speaker 4: It has become a bit more controversial. But you know, 259 00:14:34,480 --> 00:14:37,280 Speaker 4: it's a medicine like any other medications, and if you 260 00:14:37,400 --> 00:14:39,480 Speaker 4: just look at the science, it does seem to be 261 00:14:39,800 --> 00:14:43,960 Speaker 4: effective in treatment resistant depression. But if you get opioids 262 00:14:43,960 --> 00:14:47,720 Speaker 4: and things like that, pain medications are misused, So any 263 00:14:48,080 --> 00:14:50,320 Speaker 4: drug really can be misused. But I think the key 264 00:14:50,320 --> 00:14:54,560 Speaker 4: thing is for us in mental health is providing access 265 00:14:54,600 --> 00:14:56,560 Speaker 4: to it in such a way that's safe. It's in 266 00:14:56,600 --> 00:14:59,520 Speaker 4: a controlled setting, it's not going to be diversion to 267 00:14:59,560 --> 00:15:02,880 Speaker 4: recreation users, and it's not going to cause further problems 268 00:15:02,920 --> 00:15:03,480 Speaker 4: for patients. 269 00:15:03,640 --> 00:15:08,640 Speaker 3: Your colleague, Professor Colleen lou She described accessibility to be 270 00:15:08,920 --> 00:15:12,520 Speaker 3: the next challenge for the treatment. Where do you see 271 00:15:12,640 --> 00:15:16,760 Speaker 3: ketamine treatment moving in Australia in the next five to 272 00:15:16,840 --> 00:15:17,440 Speaker 3: ten years. 273 00:15:17,760 --> 00:15:21,560 Speaker 4: Yeah, that's an excellent question. Look, I think the accessibility 274 00:15:21,640 --> 00:15:25,920 Speaker 4: question really it's getting this MBS item number. The Medicare 275 00:15:25,920 --> 00:15:28,520 Speaker 4: item number is going to be critical. If that gets up, 276 00:15:28,520 --> 00:15:31,680 Speaker 4: that will mean a broader section of the community can 277 00:15:31,760 --> 00:15:35,160 Speaker 4: access the treatment. I imagine it will become rolled out 278 00:15:35,360 --> 00:15:38,360 Speaker 4: into public mental health. Obviously, there need to be an 279 00:15:38,440 --> 00:15:41,960 Speaker 4: infrastructure there and all the appropriate training and all the 280 00:15:42,040 --> 00:15:44,720 Speaker 4: knowledge that goes into this. Because it is quite a 281 00:15:44,720 --> 00:15:49,760 Speaker 4: specialized treatment, it will become more mainstream for treatment resistant depression. 282 00:15:50,360 --> 00:15:53,400 Speaker 4: There is enough data now to say that it's effective 283 00:15:53,400 --> 00:15:55,720 Speaker 4: and safe. I think it'll be also getting it out 284 00:15:55,760 --> 00:15:59,160 Speaker 4: into regional senses as well. That'll be exciting to see 285 00:15:59,200 --> 00:16:01,560 Speaker 4: it rolled out and available to more people. 286 00:16:03,200 --> 00:16:05,880 Speaker 2: I think that was a really interesting chat. I know 287 00:16:05,960 --> 00:16:08,240 Speaker 2: I learned a lot from it. If you did, too, 288 00:16:08,560 --> 00:16:11,360 Speaker 2: send it to a friend. It might be a conversation starter. 289 00:16:11,480 --> 00:16:13,520 Speaker 2: You never know. Have a great day, and we'll be 290 00:16:13,560 --> 00:16:14,400 Speaker 2: back again tomorrow